These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients. Leibovitz E; Beniashvili M; Zimlichman R; Freiman A; Shargorodsky M; Gavish D Am J Hypertens; 2003 Sep; 16(9 Pt 1):715-8. PubMed ID: 12944027 [TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. Ge CJ; Lu SZ; Chen YD; Wu XF; Hu SJ; Ji Y Heart Vessels; 2008 Mar; 23(2):91-5. PubMed ID: 18389332 [TBL] [Abstract][Full Text] [Related]
11. [One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy]. Simonyi G; Ferenci T Orv Hetil; 2016 Mar; 157(11):425-9. PubMed ID: 26947091 [TBL] [Abstract][Full Text] [Related]
12. Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy. Jukema JW; van der Hoorn JW Expert Opin Pharmacother; 2004 Feb; 5(2):459-68. PubMed ID: 14996641 [TBL] [Abstract][Full Text] [Related]
13. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea. Liew D; Park HJ; Ko SK Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890 [TBL] [Abstract][Full Text] [Related]
14. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Stone PH; Lloyd-Jones DM; Kinlay S; Frei B; Carlson W; Rubenstein J; Andrews TC; Johnstone M; Sopko G; Cole H; Orav J; Selwyn AP; Creager MA; Circulation; 2005 Apr; 111(14):1747-55. PubMed ID: 15809368 [TBL] [Abstract][Full Text] [Related]
15. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE). Deedwania PC; Am Heart J; 2004 Dec; 148(6):1053-9. PubMed ID: 15632893 [TBL] [Abstract][Full Text] [Related]
16. Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events. Arca M; Gaspardone A Drugs; 2007; 67 Suppl 1():29-42. PubMed ID: 17910519 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension. Sever PS; Poulter NR; Dahlof B; Wedel H; J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984 [TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial. Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574 [TBL] [Abstract][Full Text] [Related]
19. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin. Li M; Xu A; Lam KS; Cheung BM; Tse HF Postgrad Med; 2011 Nov; 123(6):66-71. PubMed ID: 22104455 [TBL] [Abstract][Full Text] [Related]
20. Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease. Santanu G; Suhrita P; Mookerjee S; Tania K; Mita S; Pramit G; Sharmila G; Miraj M; Debdutta M Indian Heart J; 2011; 63(5):434-7. PubMed ID: 23550422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]